Baxter Healthcare Corporation recalls Exacta Mix Vented Micro-Volume Inlet
The stated reason: Affected lots may contain incorrect 0.8-micron filters.
Baxter Healthcare Corporation began a medical device recall on April 22, 2026 whose reported distribution included Ohio. FDA
What the record shows
Use of a 0.8-micron filter in place of the validated 3-micron filter may lead to reduced flow efficiency, incomplete or slower transfers of ingredients, or system alarms. This issue may lead to clinical effects such as electrolyte imbalance, m… FDA graded it Class II — use may cause temporary or medically reversible health consequences. Quantity affected: 105675. The recall is listed as ongoing. FDA
Context
By the numbers
- Date of record: April 22, 2026 FDA
- Recall number: Z-2262-2026 FDA
- Recalls in this action: 1 FDA
- Recalling firm: Baxter Healthcare Corporation FDA
- Product: Brand Name: Exacta Mix Product Name: Vented Micro-Volume Inlet Model/Catalog Number: H938175 Product Description… FDA
- Reason for recall: Affected lots may contain incorrect 0.8-micron filters. Use of a 0.8-micron filter in place of the validated 3-micron… FDA
Assembled mechanically from the source filing and The Lantern's own record database — no AI-written prose. Every figure above appears verbatim in the cited record, which is linked on this page. FDA
Sources
The source filing
| Recall number | Z-2262-2026 |
|---|---|
| Recalls in this action | 1 |
| Recalling firm | Baxter Healthcare Corporation |
| Product | Brand Name: Exacta Mix Product Name: Vented Micro-Volume Inlet Model/Catalog Number: H938175 Product Description: Tubing sets with push-on connector on one end (to attach to the Fluid Selector Valve) and a spike or other appropriate connector on the opposite end to attach the source container. |
| Reason for recall | Affected lots may contain incorrect 0.8-micron filters. Use of a 0.8-micron filter in place of the validated 3-micron filter may lead to reduced flow efficiency, incomplete or slower transfers of ingredients, or system alarms. This issue may lead to clinical effects such as electrolyte imbalance, metabolic instability, delayed recovery, etc. |
| Classification | Class II — use may cause temporary or medically reversible health consequences |
| Recall type | medical device |
| Quantity | 105675 |
| Status | Ongoing |
| Voluntary or mandated | Voluntary: Firm initiated |
| Initiated | 20260422 |
| Reported | 20260610 |
| Distribution | Worldwide - US Nationwide distribution including in the states of Alabama, Arkansas, Arizona, California, Colorado, Florida, Georgia, Hawaii, Iowa, Idaho, Illinois, Indiana, Kansas, Kentucky, Louisiana, Massachusetts, Maine, Maryland, Michigan, Minnesota, Missouri, Mississippi, Montana, North Carolina, North Dakota, Nebraska, New Hampshire, New Jersey, New Mexico, Nevada, New York, Ohio, Oklahoma, |
| Firm location | Deerfield, IL, United States |
Published by U.S. Food and Drug Administration (openFDA). This is the agency's public filing as The Lantern received it, shown with its fields named in plain English.